Conduit Pharmaceuticals Inc (NASDAQ:CDT) traded at $3.13 at last check on current trade day and made a downward move of -5.11% on its previous day’s price.
Looking at the stock we see that its previous close was $3.30 and the beta (5Y monthly) reads 2.118 with the day’s price range being $3.01 – $3.97. In terms of its 52-week price range, CDT has a high of $392.00 and a low of $2.94. The company’s stock has lost about -47.02% over that past 30 days.
Conduit Pharmaceuticals Inc has a market cap of $4.81 million and is expected to release its quarterly earnings report in February.
On the other hand, looking at the outlook for the CDT stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Looking further, we note the current price level is -56.17% off its SMA20 and -61.25% from its 50-day simple moving average. The RSI (14) is pointing at 33.10 while the volatility over the past week is 22.53% and jumps to 26.21% over the past one month. The beta value is 2.21, while the average true range (ATR) is currently pointing at 1.88.
Coming back to Conduit Pharmaceuticals Inc (NASDAQ:CDT), we note that the average 3-month trading volume was 532.04K, while that of the preceding 10-day period stands at 146.67 million. Current shares outstanding are 0.96 million.
The insiders hold 38.12% of the company’s shares while institutions hold 3.53%. The data shows that short shares as of 2024-10-31, stood at 3.57 million at a short ratio of 0.14. This represents a 542.00 short interest in shares outstanding on 2024-10-31. Shares short rose in October from the previous month at 1.45 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -54.35% down in year-to-date price movement.
